World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes.

Bernasconi, Paolo; Klersy, Catherine; Boni, Marina; Cavigliano, Paola M; Calatroni, Silvia; Giardini, Ilaria; Rocca, Barbara; Zappatore, Rita; Caresana, Marilena; Dambruoso, Irene; Lazzarino, Mario; Bernasconi, Carlo

Bernasconi, Paolo; Klersy, Catherine; Boni, Marina; Cavigliano, Paola M; Calatroni, Silvia; Giardini, Ilaria; Rocca, Barbara; Zappatore, Rita; Caresana, Marilena; Dambruoso, Irene; Lazzarino, Mario; Bernasconi, Carlo.

Affiliation

Bernasconi P; Division of Haematology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy. p.bernasconi@smatteo.pv.it

Br J Haematol ; 137(3): 193-205, 2007 May.

Article de En | MEDLINE | ID: mdl-17408458

Sujet(s)

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links

Collection: 01-internacional Base de données: MEDLINE Sujet principal: Organisation mondiale de la santé / Syndromes myélodysplasiques / Aberrations des chromosomes Type d'étude: Prognostic_studies / Risk_factors_studies Limites: Adult / Aged / Female / Humans / Male / Middle aged Langue: En Journal: Br J Haematol Année: 2007 Type de document: Article Pays d'affiliation: Italie

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links